Cite
MLA Citation
Peter M K de Blank et al.. “MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.” Neuro-oncology, vol. 24, no. 11, 2022, pp. 1845–1856. http://access.bl.uk/ark:/81055/vdc_100169532815.0x000023